Komal Jhaveri, MD, FACP, a medical oncologist at Memorial Sloan Kettering Cancer Center, discusses sequencing treatments for patients with metastatic HER2-positive breast cancer.
Dr. Jhaveri on Implications of the DESTINY-Breast03 Trial in HER2+ Breast Cancer Top 8 Trials From 2021 in Breast Cancer Data With Antibody-Drug Conjugates and TKIs Impress in HER2+ Breast CancerNewsletter Stay up to date on the most recent and practice-changing oncology data Subscrib...
www.spinehospital.in Dr. Subir N. Jhaveri Jyoti Plaza, Shyamal cross Rd, Ahd. Ph.: 26732040, (m): 9824036686 www.spinesurgery.in Pathology Endocrine Laboratory 40, Sangathan society, Opp. Sunrise Park, Drive-in Rd, Ahd-52. Ph.: 27913309,27913114. Green Cross Laboratory Paldi Ph.: ...
Precision Medicine in Oncology® Sarcomas Supportive Care Spotlight - In-person and virtual events just for HCPs CME Opportunities Choose Specialty Newsletter Stay up to date on the most recent and practice-changing oncology data Subscribe Now!
Latest Conference Coverage Oncology Experts Preview Top Abstracts From AUA 2025 Future of Bispecifics and CAR T in R/R MM Choosing Between Bispecifics and CAR T: Real-World Implications in R/R MM Overview of iMMagine-1 Trial: Phase 2 Registrational Study of Anitocabtagene Autoleucel for ...
Stay up to date on the most recent and practice-changing oncology data Subscribe Now! Related Videos Dr Shah on Zamtocabtagene Autoleucel’s Favorable Safety Profile in R/R DLBCL Dr Bryce on the Comparative Efficacy of ARPIs Regardless of Disease Volume or Timing of Metastases in mHSPC ...
Related Content View More OncLive TVMantle Cell LymphomaHematologic OncologyMarch 12th 2025 BOVen Regimen is Safe and Effective in First-Line TP53-Mutated MCL February 18th 2025 Inavolisib Has a Favorable Risk-Benefit Profile for PIK3CA-Mutant, HR+ Metastatic Breast Cancer: With Komal Jhaveri, MD...
Stay up to date on the most recent and practice-changing oncology data Subscribe Now! Related Videos Dr Camidge on Best Practices for Biomarker Testing in NSCLC Dr Patel on the Potential for Adjuvant Immunotherapy in CSCC Dr Hinchcliff on the Benefits of Chemoimmunotherapy in Endometrial Cancer ...
Stay up to date on the most recent and practice-changing oncology data Subscribe Now! Related Videos Dr Gupta on Considerations for Frontline Treatment Selection in HR+/HER2-Negative Breast Cancer Dr Alawadhi on the Link Between Obesity/Overweight and Breast Cancer Outcomes ...
Roisin E. O'Cearbhaill, MD, gynecologic oncologist, cellular therapist, associate attending physician, research director, Gynecologic Medical Oncology Service, clinical director, Solid Tumor, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, discusses key findings from a ...